Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01582789 · ClinicalTrials.gov registry record · NA
Comparative Study of Two Marketed Spherical Soft Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01582789 is a NA study that has completed, run by CooperVision. The registered enrollment target is 61 participants.
The verdict
NCT01582789, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain objective and subjective clinical data to compare the performance of two soft contact lenses.
Interventions
- DEVICE senofilcon A
- DEVICE enfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2012-04-09 |
| Est. Completion | 2012-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01582789
The ClinicalTrials.gov registry entry for NCT01582789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which senofilcon A is the first listed.
NCT01582789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01582789 about?
NCT01582789 is a clinical study titled "Comparative Study of Two Marketed Spherical Soft Contact Lenses". The purpose of this study is to obtain objective and subjective clinical data to compare the performance of two soft contact lenses.
What is the current status of trial NCT01582789?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2012-04-09. Estimated completion is 2012-07-31.
What interventions are being tested in trial NCT01582789?
The interventions under investigation include: senofilcon A (DEVICE), enfilcon A (DEVICE).
Who is sponsoring clinical trial NCT01582789?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.